StockClub

News

Jul 31 (Fri)
RegulationFirst Solar, Inc.FSLRNewsfile Corp

Kaplan Fox Encourages First Solar, Inc. (FSLR) Investors with Losses to Contact the Firm Before August 24, 2026

New York, New York--(Newsfile Corp. - July 31, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against First Solar, Inc. ("First Solar" or the "Company") (NASD

EarningsLIXIL CorporationJSGRYSeeking Alpha

LIXIL Corporation (JSGRY) Q1 2027 Earnings Call Transcript

LIXIL Corporation (JSGRY) Q1 2027 Earnings Call Transcript

MacroAmazon.com, Inc.AMZNCNBC

Dwindling cash and soaring memory costs: Tech's AI buildout has ballooning price tag

Amazon, Alphabet and Tesla all reported negative cash flow in the latest quarter, while Meta's cash generation plummeted by 91%. The AI buildout is having a massive impact on corporate balance sheets,

City Holding CompanyCHCOProactive Investors

Lloyds targets look conservative, City analysts say

Lloyds Banking Group PLC (LSE:LLOY) won a broadly positive response from City analysts after its half-year results and strategy update, with brokers arguing that its new targets may prove conservative

Steakholder Foods Ltd.STKHGlobeNewsWire

Steakholder Foods Ltd. Announces Up To $10.5 Million Private Placement

$3.5 million upfront with up to approximately $7 million of potential additional gross proceeds upon the exercise in full of warrants

IPOBitGo Holdings, Inc.BTGONewsfile Corp

Kaplan Fox Encourages BitGo Holdings, Inc. (BTGO) Investors with Losses to Contact the Firm Before August 7, 2026

New York, New York--(Newsfile Corp. - July 31, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against BitGo Holdings, Inc. ("BitGo" or the "Company") (NYSE: B

Amplia Therapeutics LimitedINNMFGlobeNewsWire

Scientific Paper Detailing Preclinical Studies of Narmafotinib in Pancreatic Cancer Now Online

HIGHLIGHTS A manuscript describing comprehensive preclinical studies of narmafotinib in models of pancreatic cancer is now available online. The findings provide further evidence of narmafotinib's abi

Sponsored
OtherMCNGlobeNewsWire

MCN Adjourns Special Meeting of Shareholders Until August 26, 2026

CHICAGO, July 31, 2026 (GLOBE NEWSWIRE) -- XA Investments, LLC, manager of XAI Madison Equity Premium Income Fund (MCN) (the “Fund”) announced it has adjourned the Fund's Special Meeting of Shareholde

EarningsSeeking Alpha

Hang Lung Group Limited (HNLGY) Q2 2026 Earnings Call Transcript

Hang Lung Group Limited (HNLGY) Q2 2026 Earnings Call Transcript

ZOZO, Inc.SRTTYSeeking Alpha

ZOZO, Inc. (SRTTY) Q1 2027 Earnings Call Prepared Remarks Transcript

ZOZO, Inc. (SRTTY) Q1 2027 Earnings Call Prepared Remarks Transcript

RegulationThe New York Times CompanyNYTCNBC

New York sues Kalshi, says prediction market is running 'illegal gambling operation'

New York state on Friday sued Kalshi in a Manhattan state court, claiming that the company is illegally operating a gambling platform. Kalshi expressed disappointment with the decision by the state, s

Reckoner Yield Enhanced AAA CLO ETFRAAAETF Trends

Navigate a Challenging Fixed Income Environment With CLOs

In a tricky fixed income environment marked by high interest rates and ongoing monetary policy uncertainty, collateralized loan obligations (CLOs) are emerging as a strategic alternative. However, inv

SciSparc Ltd.SPRCGlobeNewsWire

SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics

TEL AVIV, Israel, July 31, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage phar

WELL Health Technologies Corp.WHTCFNewsfile Corp

WELL Health Subsidiary WELLSTAR Closes C$50 Million Financing Transaction Ahead of Planned TSXV Listing

Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health outc

Sponsored
IPOPicS N.V.PICSNewsfile Corp

Kaplan Fox Alerts Investors of a Securities Class Action Against PicS N.V. (PICS) - Deadline is August 4, 2026

New York, New York--(Newsfile Corp. - July 31, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PicS N.V. ("PicS" or the "Company") (NASDAQ: PICS) on be

DividendIRadimed CorporationIRMDGlobeNewsWire

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $20.5 million for the second quarter of 2026, which increased by

OtherBadger Meter, Inc.BMINewsfile Corp

Kaplan Fox Encourages Badger Meter, Inc. (BMI) Investors with Losses to Contact the Firm Before August 3, 2026

New York, New York--(Newsfile Corp. - July 31, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Badger Meter, Inc. ("Badger Meter" or the "Company") (NY

EarningsEngie S.A.ENGIYSeeking Alpha

Engie SA (ENGIY) Q2 2026 Earnings Call Transcript

Engie SA (ENGIY) Q2 2026 Earnings Call Transcript

OtherFulcrum Therapeutics, Inc.FULCSeeking Alpha

Fulcrum Therapeutics: Buy It For The Strategic Reset

Fulcrum is trading at a deep discount due to operational distress after the suspension of their main program. But because of their fortress balance sheet, Fulcrum should have the financial strength to

OtherGlobe News Wire

Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients

Prior venetoclax failure - a setting in which published salvage remission rates are approximately 13% and median survival approximately 2. 4 months - shows no adverse impact on blinded composite remis